Quick Answer
Pharvaris N.V. reported R&D Expense of $98.56 million for fiscal year 2024.
Pharvaris N.V. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $98.56M | +50.3% |
| 2023 | $65.58M | +14.3% |
| 2022 | $57.38M | +60.3% |
| 2021 | $35.79M | +83.5% |
| 2020 | $19.51M | +243.2% |
| 2019 | $5.68M | +55.9% |
| 2018 | $3.65M | — |
- Pharvaris N.V. showed an increase of +50.3% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2024 period, Pharvaris N.V.’s r&d expense has grown by 2603.8% (from $3.65 million to $98.56 million).
- The most recent figure is from Pharvaris N.V.’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: